Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term acute lymphoblastic-leukemia. Found 11 abstracts

Cukierman E, Bassi DE. The mesenchymal tumor microenvironment A drug-resistant niche. Cell Adhesion & Migration. 2012 May;6(3):285-96.   PMCID: PMC3427243
Rao SY, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu ZG, Jeffers JR, Rhodes M, Anderson S, Oravecz T, Hunger SP, Timakhov RA, Zhang RG, Balachandran S, Zambetti GP, Testa JR, Look AT, Wiest DL. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012 Nov;120(18):3764-73.   PMCID: PMC3488889
Tang BQ, Testa JR, Kruger WD. Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells. Cancer Biology & Therapy. 2012 Sep;13(11):1082-90.   PMCID: PMC3461818
Robinson BW, Germano G, Song YQ, Abrams J, Scott M, Guariento I, Tiso N, Argenton F, Basso G, Rhodes J, Kanki JP, Look AT, Balice-Gordon RJ, Felix CA. mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues. British Journal of Haematology. 2011 Feb;152(3):307-21.   PMCID: PMC3158705
De Keersmaecker K, Real PJ, Della Gatta G, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Soulier J, Avran D, Cave H, Dastugue N, Raimondi S, Meijerink JP, Cordon-Cardo C, Califano A, Ferrando AA. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature medicine. 2010 Nov;16(11):1321-7.   PMCID: PMC2974790
Huo HR, Magro PG, Pietsch EC, Patel BB, Scotto KW. Histone Methyltransferase MLL1 Regulates MDR1 Transcription and Chemoresistance. Cancer Research. 2010 Nov;70(21):8726-35.   PMCID: *
Yu EY, Wilding G, Posadas E, Gross M, Culine S, Massard C, Morris MJ, Hudes G, Calabro F, Cheng ST, Trudel GC, Paliwal P, Sternberg CN. Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 2009 Dec;15(23):7421-8.   PMCID: PMC 3394097
Nebozhyn M, Loboda A, Kati L, Rook AH, Vonderheid EC, Lessin S, Berger C, Edelson R, Nichols C, Yousef M, Gudipati L, Shang ML, Showe MK, Showe LC. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. BLOOD. 2006 Apr;107(8):3189-96.
Guo P, Wang XM, Zhou F, Gallo JM. Determination of vincristine in mouse plasma and brain tissues by liquid chromatography-electrospray mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2004 Oct 05;809(2):273-8.
Zeng XX, Zhang HG, Hardy RR, Wasserman R. The fetal origin of B-precursor leukemia in the E mu-ret mouse. Blood. 1998 Nov 15;92(10):3529-36.
Shpitz B, Chambers CA, Singhal AB, Hozumi N, Fernandes BJ, Roifman CM, Weiner LM, Roder JC, Gallinger S. High-Level Functional Engraftment of Severe Combined Immunodeficient Mice with Human Peripheral-Blood Lymphocytes Following Pretreatment with Radiation and Anti-Asialo G(M1). Journal of Immunological Methods. 1994 Feb 28;169(1):1-15.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term acute lymphoblastic-leukemia

acute lymphoblastic-leukemia expression deficient gene p-glycoprotein gene-expression drosophila-trithorax lymphocytes hmg-coa reductase MLL zebrafish-molecular cloning-primitive haematopoiesis-definitive haematopoiesis l-plastin gene strategies h3k4 methylation trail-induced apoptosis embryo tyrosine kinase inhibitor lymphoma transferase-positive cells tyrosine kinase endothelial versus-host codeletion severe combined immunodeficient mouse ontogeny mice activation natural killer cell nf-y imatinib-resistant lymphomagenesis graft growth-factor multiple-myeloma cells mycosis-fungoides children t-plastin antigen presentation t-cell development mitoxantrone plus prednisone mutations solid src family kinases minimal residual disease bcl11b tumor-stromal interactions tumor microenvironment-stromal-induced drug resistance-extracellular matrix-tumor-associated or carcinoma-associated fibroblasts-matrix-induced drug resistance-mesenchymal stroma pro- bone metastases p53 immunoglobulin heavy-chain chromatin 5'-methylthioadenosine survival pancreatic-cancer tumors vinca-alkaloids methylthioadenosine phosphorylase gene hu mouse Hematology joining mechanism b disposition extraction mutant mice adhesion-mediated drug nucleosides junctional sequences transgenic mice prognostic-factors purine chemotherapy-mesothelioma-osteosarcoma-methionine predict survival definitive hematopoiesis multidrug-resistance translational control invivo responses cancer homozygous deletions chronic bone-marrow microenvironment mononuclear-cells interleukin-12 therapy bone-marrow amino-terminus graft versus host disease xenogeneic notch1 vincristine disease protein urine hox11 sulfate liposome injection stem-cells nf-kappa-b zoledronic acid pbl-scid mice cytogenetic cdkn2 breast-cancer cells inhibition model cell-cycle pharmacokinetics clonal evolution myeloid-leukemia human t-cells sezary-syndrome drug disposition gene rearrangements
Last updated on Wednesday, February 05, 2020